PRELLIS BIOLOGICS
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.
PRELLIS BIOLOGICS
Industry:
3D Printing Biopharma Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.prellisbio.com
Total Employee:
11+
Status:
Active
Contact:
510-200-7698
Email Addresses:
[email protected]
Total Funding:
79.37 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Content Delivery Network Global Site Tag Cloudflare JS Google CDN JS Google Cloud BootstrapCDN
Similar Organizations
Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
SOSV
SOSV investment in Series C - Prellis Biologics
IndieBio
IndieBio investment in Series C - Prellis Biologics
Lucas Venture Group
Lucas Venture Group investment in Series C - Prellis Biologics
IndieBio
IndieBio investment in Series C - Prellis Biologics
True Ventures
True Ventures investment in Series C - Prellis Biologics
SOSV
SOSV investment in Series C - Prellis Biologics
Avidity Partners
Avidity Partners investment in Series C - Prellis Biologics
Celesta Capital
Celesta Capital investment in Series C - Prellis Biologics
Black Diamond Ventures
Black Diamond Ventures investment in Series C - Prellis Biologics
Khosla Ventures
Khosla Ventures investment in Series C - Prellis Biologics
Key Employee Changes
Official Site Inspections
http://www.prellisbio.com Semrush global rank: 9.05 M Semrush visits lastest month: 445
- Host name: 104.26.1.183
- IP address: 104.26.1.183
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Prellis Biologics"
Prellis Biologics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 510-200-7698 Prellis Biologics is building human tissues for drug development, and ultimately, developing …See details»
About Prellis Biologics: Pioneering Antibody Therapeutics
Integrating human biology with machine learning. We aim to revolutionize drug discovery by harnessing the power of the human immune system with tightly …See details»
Careers at Prellis Biologics: Join Our Team
Explore career opportunities at Prellis Biologics. Advance antibody discovery and collaborate with top talent in an innovative and dynamic biotech environment.See details»
Prellis Biologics - LinkedIn
Prellis Biologics | 8,132 followers on LinkedIn. Integrating human biology with machine learning for antibody discovery | Prellis Bio is hiring Immunologists! We are expanding our Externalized ...See details»
Prellis Biologics - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Prellis Biologics of Berkeley, CA. Get the latest business insights from Dun & Bradstreet.See details»
Prellis Biologics Company Overview, Contact Details
Apply at www.prellisbio.com. Sign up for free to view info. Email Format Employee directory . Company Overview. Headquarters 999 Anthony St. Berkeley, California 94710 US. Website …See details»
Prellis Biologics 2025 Company Profile: Valuation, Funding
Prellis Biologics General Information Description. Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. The company's technology precisely …See details»
Prellis Biologics - Overview, News & Similar companies - ZoomInfo
Dec 15, 2021 Prellis Biologics contact info: Phone number: (415) 742-1283 Website: www.prellisbio.com What does Prellis Biologics do? Founded in 2016 and headquartered in …See details»
Prellis Biologics - The Org
Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXIS™, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in …See details»
Prellis Biologics (USA) Funding: $79.4M - Medical Startups
Mar 11, 2025 USA | Funding: $79.4M Website: https://www.prellisbio.com Prellis employs holographic tissue printing technology with rapid fully human antibody discovery, in vitro …See details»
Prellis Biologics - VentureRadar
Website: https://www.prellisbio.com. Offers a platform that recreates human immunobiology using 3D printed lymph node organoids for antibody discovery and immunogenicity assessment. …See details»
Prellis Biologics - IndieBio - #1 in Early Stage Biotech
Prellisbio.com * Data source: Crunchbase. Melanie Matheu, PhD, CEO & Founder. A surgeon identified a singular problem standing between scientists and physicians and a truly living …See details»
Prellis Biologics - Craft
Prellis Biologics has 5 employees at their 1 location and $11.05 m in total funding,. See insights on Prellis Biologics including office locations, competitors, revenue, financials, executives, …See details»
Working At Prellis Biologics: Company Overview and Culture - Zippia
Www.prellisbio.com. Organization Type. Private. CEO. Melanie Matheu. Social Media. Prellis Biologics is building human tissues for drug development, and ultimately, developing human …See details»
Prellis Biologics - workinbiotech.com
Prellis Biologics is an organ and tissue engineering company using holographic bioprinting to revolutionize transplantation procedures. Immune rejection has made supplying organ …See details»
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C ...
Aug 10, 2022 Learn more at prellisbio.com. ABOUT CELESTA. Celesta Capital is a leading deep technology venture capital firm that leverages synergies between leading centers of …See details»
Prellis Biologics EXIS™: Revolutionizing Antibody Discovery
EXIS™ Platform: Pioneering Precision in Antibody Discovery. EXIS™ unlocks the human immune system for true human antibody discovery and exploits the large genetic diversity from multiple …See details»
Inside the futuristic biotech startup Cellares that’s building a cure ...
4 days ago Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»
Partner with Prellis: Accelerate Antibody Discovery
Agility. We understand that time is of the essence in the world of drug discovery. Our state-of-the-art technology and streamlined processes allow us to rapidly screen and characterize antibody …See details»
Prellis Biologics News: Updates & Press Releases
Press Releases · May 19, 2020. Prellis Biologics, Inc. Generates 300 Human Antibodies That Bind the SARS-CoV2 Virus; Pursues Development of a Treatment and Preventative Therapy …See details»